about
Endemic pemphigus in the Peruvian Amazon: epidemiology and risk factors for the development of complications during treatment.Multivessel acute myocardial infarction: case report and review of the literature.Microarray technique, analysis, and applications in dermatology.Acute generalized exanthematous pustulosis: atypical presentations and outcomes.Pathophysiology of pyoderma gangrenosum (PG): an updated review.Pyoderma gangrenosum and pregnancy: an example of abnormal inflammation and challenging treatment.Skin diseases in the Peruvian Amazonia.Aspirin desensitization/challenge in 3 patients with unstable angina.Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility.Images in clinical medicine. Cutaneous blastomycosis.Endemic pemphigus vulgaris.Endemic pemphigus foliaceus in the Peruvian Amazon.Images in the medical sciences. Night blindness in a patient with acquired immunodeficiency syndrome.A rapidly progressive and fatal case of atypical acute generalized exanthematous pustulosis.Dysregulation of inflammatory gene expression in lesional and nonlesional skin of patients with pyoderma gangrenosum.Antidesmoglein 1 and 3 antibodies in healthy subjects of a population in the Peruvian high amazon.Eosinophilic fasciitis in a female child.Noninfectious dermatological diseases associated with chronic exposure to mine tailings in a Peruvian districtUpdate on the characterization of Staphylococcus aureus skin infections in a pediatric dermatology tertiary health care outpatient facility: antibiotic susceptibility patterns and decreased methicillin resistanceCutaneous acanthamebiasis infection in immunocompetent and immunocompromised patients
P50
Q36977672-4B5A60EA-905F-4598-957E-40A8F004443DQ37163998-C8A58E90-69B3-4069-A3D6-2F5600432CA1Q38088944-D0225E7A-DB76-4A6D-94E9-0238EE14F64FQ38247247-0F367962-6F0E-484A-8D50-B683250D4E27Q38562618-0DF32F95-01D9-4B5B-8883-85B7B4D1692EQ38609124-31A2FA73-6316-4DEC-AE1F-10F3582D12ADQ39037853-2DF4F772-5540-4220-86B9-C35199BA4E9DQ42925598-BEC0B5F1-F0DD-42B1-A46F-720D3C81289EQ43153744-75D6B2F9-FEC5-4C61-9AE0-4AA158A97ED4Q43897937-FAD7BCFF-7CF0-411C-9E0A-11DCE8EE9196Q44003062-351F4AFB-07A8-4721-AB7C-02EC64EAE435Q44205342-8EADC317-BA8A-4873-B129-28E1C7B98D93Q44951616-D1CB6424-597F-4541-A948-451E9644A0F6Q45001898-73275064-1695-4AF0-811A-A9F1EDFDCAACQ45063901-F906979D-A42B-4BAE-BEED-BE93E93623A0Q48318751-E4B7DC94-98DB-4F04-AC87-26D37A69F518Q51698823-6F0B1FB3-0AC6-41E1-A0F6-298563D79A04Q81355439-0D12827E-6946-4878-BF18-DFA83D535433Q83215246-3B3C204A-7B81-4CDD-8629-A460805F4541Q84102046-93478F75-980E-43AE-BEF6-BF99C6376628
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Alex G Ortega-Loayza
@en
Alex G Ortega-Loayza
@nl
type
label
Alex G Ortega-Loayza
@en
Alex G Ortega-Loayza
@nl
prefLabel
Alex G Ortega-Loayza
@en
Alex G Ortega-Loayza
@nl
P31
P496
0000-0001-5028-9269